News

healthcare surprise billing statement payment

Radiologists implore HHS to punish payers who undermine surprise-billing protections

Over 100 specialty societies and state medical associations wrote to Health and Human Services and other departments to voice their growing frustration with the No Surprises Act.

Interventional radiology group inks 2 more practice partnerships with urologists

Founded by interventional radiologist Sandeep Bagla, MD, IR Centers is a platform helping other specialties manage and deliver such services.

M&A mergers and acquisitions business deal

Radiology AI vendor Azra acquires rival firm focused on incidental findings

The Nashville, Tennessee, company—which offers AI to monitor radiology reports for unexpected findings—has reached a deal to buy Thynk Health for an undisclosed sum.

6 things the hospital-at-home model needs to scale up nationally

Earlier this year Congress extended CMS’s hospital-at-home waiver for five years via the Consolidated Appropriations Act of 2026. With that bold stroke, ‘HaH’ services became eligible for Medicare reimbursement through September of 2030.

IV fluids recalled over possible contamination—patients face risk of vascular complications

Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.

Fearless futurist: ‘In Phase One, AI felt like software. In Phase Two, it feels like a new species of workforce.’

The nonfiction book market is flooded with titles mentioning AI or artificial intelligence. Here’s a new work that will shake your world whether you’re an AI lover, loather or someone in between.

FDA warns public about vascular device after 3 deaths

The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

cvi42 | Plaque Circle Cardiovascular Imaging

How to implement AI-powered coronary plaque analysis software—and ensure you get paid

The use of AI to evaluate plaque buildup in CCTA images has been one of cardiology’s biggest ongoing trends. Implementing this software into existing workflows, however, can be a challenge. An upcoming webinar is focused on providing guidance to hospitals and cardiology practices hoping to learn more about this topic.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

New gene therapy for rare heart condition gains FDA’s fast track designation

Catecholaminergic polymorphic ventricular tachycardia is a rare, potentially fatal heart rhythm disorder. A new gene therapy candidate from Solid Biosciences is now one step closer to FDA approval.

Philips UroNav system gains FDA clearance

FDA clears fusion image navigation system for prostate cancer therapy planning

The fusion technology integrates pre-procedural MR images of the prostate with intraprocedural ultrasound images in real-time.

Joshua Joseph, MD, MPH, FAHA an expert in Cardiovascular-Kidney-Metabolic (CKM) syndrome, associate professor of internal medicine, and the Endowed Professor for Research in Internal Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center, explains the CKM advisory from the American Heart Association designed to help define and stage the disease. CKM has seen a large amount of growing interest from cardiologists in recent years.

Interest rising in CKM syndrome as connections become clearer

Cardiovascular-kidney-metabolic (CKM) syndrome is a popular research topic among cardiologists, highlighting just how closely obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease are related to one another. Joshua Joseph, MD, spoke to Cardiovascular Business about this ongoing trend.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Complications after intravascular lithotripsy are rare, real-world data confirm

Shockwave Medical, now a part of Johnson & Johnson MedTech, has consistently been found safe for patients. However, many previous clinical trials excluded high-risk patients, making it important to track real-world outcomes as time goes on.

Around the web

Radiology Business

Radiologists implore HHS to punish payers who undermine surprise-billing protections

Over 100 specialty societies and state medical associations wrote to Health and Human Services and other departments to voice their growing frustration with the No Surprises Act.

Radiology Business

Interventional radiology group inks 2 more practice partnerships with urologists

Founded by interventional radiologist Sandeep Bagla, MD, IR Centers is a platform helping other specialties manage and deliver such services.

Radiology Business

Radiology AI vendor Azra acquires rival firm focused on incidental findings

The Nashville, Tennessee, company—which offers AI to monitor radiology reports for unexpected findings—has reached a deal to buy Thynk Health for an undisclosed sum.